Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
1.1. Discovery of the Phospholipase A2 Superfamily Phospholipases represent one of the
earliest enzyme activities to be identified and studied, and the phospholipase A2 (PLA2) …
earliest enzyme activities to be identified and studied, and the phospholipase A2 (PLA2) …
The metabolic serine hydrolases and their functions in mammalian physiology and disease
JZ Long, BF Cravatt - Chemical reviews, 2011 - ACS Publications
Serine hydrolases (SHs) consist of> 200 enzymes in humans characterized by the presence
of an active site serine that is used for the hydrolysis of substrates. The membership of this …
of an active site serine that is used for the hydrolysis of substrates. The membership of this …
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists
MH Davidson, CM Ballantyne, TA Jacobson… - Journal of clinical …, 2011 - Elsevier
The National Cholesterol Education Program Adult Treatment Panel guidelines have
established low-density lipoprotein cholesterol (LDL-C) treatment goals, and secondary non …
established low-density lipoprotein cholesterol (LDL-C) treatment goals, and secondary non …
Inflammation and atherosclerosis—revisited
S Pant, A Deshmukh, GS GuruMurthy… - Journal of …, 2014 - journals.sagepub.com
Atherogenesis has been traditionally viewed as a metabolic disease representing arterial
obstruction by fatty deposits in its wall. Today, it is believed that atherogenesis involves …
obstruction by fatty deposits in its wall. Today, it is believed that atherogenesis involves …
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
JJP Kastelein, KC Maki, A Susekov, M Ezhov… - Journal of clinical …, 2014 - Elsevier
Background Omega-3 fatty acids in free fatty acid form have enhanced bioavailability, and
plasma levels are less influenced by food than for ethyl ester forms. Objective The aim was …
plasma levels are less influenced by food than for ethyl ester forms. Objective The aim was …
Metabolism and atherogenic disease association of lysophosphatidylcholine
G Schmitz, K Ruebsaamen - Atherosclerosis, 2010 - Elsevier
Lysophosphatidylcholine (LPC) is a major plasma lipid that has been recognized as an
important cell signalling molecule produced under physiological conditions by the action of …
important cell signalling molecule produced under physiological conditions by the action of …
Chronic inflammatory diseases and cardiovascular risk: a systematic review
Despite recent advancements in the treatment of coronary artery disease (CAD), it remains
the number one cause of death in the world. While traditional risk factors partially account for …
the number one cause of death in the world. While traditional risk factors partially account for …
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines
MH Davidson, MA Corson, MJ Alberts… - The American journal of …, 2008 - Elsevier
A consensus panel was formed to review the rapidly emerging literature on the vascular-
specific inflammatory marker lipoprotein-associated phospholipase A2 (Lp-PLA2) and to …
specific inflammatory marker lipoprotein-associated phospholipase A2 (Lp-PLA2) and to …
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group
The concepts of “cardiometabolic risk,”“metabolic syndrome,” and “risk stratification” overlap
and relate to the atherogenic process and development of type 2 diabetes. There is …
and relate to the atherogenic process and development of type 2 diabetes. There is …
Oxidized phospholipids and lipoprotein‐associated phospholipase A2 (Lp‐PLA2) in atherosclerotic cardiovascular disease: An update
Inflammation and oxidative stress conditions lead to a variety of oxidative modifications of
lipoprotein phospholipids implicated in the occurrence and development of atherosclerotic …
lipoprotein phospholipids implicated in the occurrence and development of atherosclerotic …